Skip to main content

UNC Clinical Research Community,

In the setting of pandemic restrictions beginning to be relaxed by UNC Health, UNC Investigational Drug Services (IDS) plans to begin to allow select onsite monitoring visits.

Please refer to the attached memo for additional details.

This policy is in effect as of June 29th, 2021 for all monitoring visits not yet scheduled. IDS will follow previously existing policy for all monitor visits already scheduled.

Thank you,

Andy Thorne, PharmD, MS